G. Van Gassen et al., Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction, MOL MED, 6(7), 2000, pp. 570-580
Citations number
34
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Background: Mutations in the presenilin (PSEN) genes are responsible for th
e majority of early-onset Alzheimer disease (AD) cases. PSEN1 is a componen
t of a high molecular weight, endoplasmic reticulum, membrane-bound protein
complex, including beta-catenin. Pathogenic PSEN1 mutations were demonstra
ted to have an effect on beta-catenin and glycogen synthase kinase-3 beta(G
SK-3 beta), two members of the wingless Wnt pathway. The nuclear translocat
ion and the stability of beta-catenin, and the interaction between GSK3 bet
a and PSEN1 were influenced.
Materials and Methods: Stably transfected human embryonic kidney (HEK) 293
cells overexpressing wild-type (wt) and mutant (mt) PSEN1, treated with and
without LiCl, were used to isolate cytoplasmic and nuclear fractions. By W
estern blot analysis, endogenous beta-catenin levels were examined. By anal
yzing cytosolic fractions of PSEN1, transfected and nontransfected HEK 293
cells, and total brain extracts of AD patients and controls, we evaluated t
he effect of PSEN1 overexpression on beta-catenin stability. Finally, we an
alyzed the effect of pathogenic PSEN1 mutations on the interaction between
PSEN1 and GSK3 beta by co-immunoprecipitation experiments.
Results: We report reduced nuclear translocation of beta-catenin in cells s
tably expressing 1143T, G384A, and T113-114ins PSEN1. The G384A PSEN1 mutat
ion showed a similar pronounced effect on nuclear translocation of beta-cat
enin, as reported for processing of amyloid precursor protein (APP) into am
yloid beta(A beta) Overexpression of PSEN1 and the presence of pathogenic m
utations in PSEN1 had no significant effect on the stability of beta-cateni
n. Nonspecific binding of overexpressed PSEN1 to endogenous GSK3 beta was o
bserved when GSK3 beta was immunoprecipitated. Immunoprecipitation of PSEN1
in cells overexpressing PSEN1 and in native cells, however, did not result
in co-immunoprecipitation of endogenous GSK3 beta.
Conclusion: Our results further establish the nuclear translocation assay o
f beta-catenin as an adequate alternative for traditional A beta measuremen
t to evaluate the effect of PSEN1 mutations on biochemical processes. We de
tected no significant effect of overexpressed wt or mt PSEN1 on the stabilt
y of beta-catenin. Finally, co-immunoprecipitation between PSEN1 and GSK3 b
eta was not observed in our experimental setup.